<?xml version="1.0" encoding="UTF-8"?>
<ref id="B24">
 <label>24.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Zhou</surname>
    <given-names>Q</given-names>
   </name>, 
   <name name-style="western">
    <surname>Chen</surname>
    <given-names>V</given-names>
   </name>, 
   <name name-style="western">
    <surname>Shannon</surname>
    <given-names>CP</given-names>
   </name>, 
   <name name-style="western">
    <surname>Wei</surname>
    <given-names>XS</given-names>
   </name>, 
   <name name-style="western">
    <surname>Xiang</surname>
    <given-names>X</given-names>
   </name>, 
   <name name-style="western">
    <surname>Wang</surname>
    <given-names>X</given-names>
   </name>, 
   <name name-style="western">
    <surname>Wang</surname>
    <given-names>ZH</given-names>
   </name>, 
   <name name-style="western">
    <surname>Tebbutt</surname>
    <given-names>SJ</given-names>
   </name>, 
   <name name-style="western">
    <surname>Kollmann</surname>
    <given-names>TR</given-names>
   </name>, 
   <name name-style="western">
    <surname>Fish</surname>
    <given-names>EN</given-names>
   </name>
  </person-group>
  <year>2020</year>
  <article-title>Interferon-Î±2b treatment for COVID-19</article-title>. 
  <source>Front Immunol</source>
  <volume>11</volume>:
  <fpage>1061</fpage>. doi:
  <pub-id pub-id-type="doi">10.3389/fimmu.2020.01061</pub-id>.
  <pub-id pub-id-type="pmid">32574262</pub-id>
 </mixed-citation>
</ref>
